结论—这些研究结果表明多药抗药性相关蛋白-1和白三烯C4都有致动脉粥样硬化作用,因此两者都有可能成为抗动脉粥样硬化治疗的靶向物质。
Conclusions-: These findings indicate that MRP1 and LTC4 exert proatherosclerotic effects and that both MRP1 and LTC4 are potentially promising targets for atheroprotective therapy.
结论—这些研究结果表明多药抗药性相关蛋白-1和白三烯C4都有致动脉粥样硬化作用,因此两者都有可能成为抗动脉粥样硬化治疗的靶向物质。
Conclusions-: These findings indicate that MRP1 and LTC4 exert proatherosclerotic effects and that both MRP1 and LTC4 are potentially promising targets for atheroprotective therapy.
应用推荐